Certain thiazole-carboxamides and their pharmaceutical utility
    2.
    发明授权
    Certain thiazole-carboxamides and their pharmaceutical utility 失效
    某些噻唑甲酰胺及其制药应用

    公开(公告)号:US4027030A

    公开(公告)日:1977-05-31

    申请号:US65976076

    申请日:1976-02-20

    Applicant: ROUSSEL UCLAF

    CPC classification number: C07D277/56

    Abstract: Novel thiazole carboxamides of the formula I wherein R, R1 and R2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 6 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having a marked antilipolytic activity as well as vasodilatatory and hypoglycemic activity and their preparation.

    Abstract translation: 式Ia的新型噻唑甲酰胺其中R 1,R 2和R 2分别选自氢和1至6个碳原子的烷基及其无毒的药学上可接受的酸加成盐,其具有显着的抗水解活性, 以及血管舒张和降血糖活性及其制备。

    Basic aluminum salt of 2-N-propyl-5-thiazole-carboxylic acid
    3.
    发明授权
    Basic aluminum salt of 2-N-propyl-5-thiazole-carboxylic acid 失效
    2-N-丙基-5-噻唑羧酸的碱式铝盐

    公开(公告)号:US3925399A

    公开(公告)日:1975-12-09

    申请号:US46518874

    申请日:1974-04-29

    Applicant: ROUSSEL UCLAF

    Abstract: The basic aluminum salt of 2-n-propyl-5-thiazolecarboxylic acid having the formula

    ITS PREPARATION, HYPOLIPEMIANT COMPOSITIONS CONTAINING THE SAME AND THERAPEUTIC METHODS TO TREAT HYPERLIPEMIA UTILIZING THE HYPOLIPEMIANT COMPOSITIONS.

    Abstract translation: 具有式ITS的2-正丙基-5-噻唑甲酸的碱性铝盐,其含有其的高效组合物和治疗使用高效组合物的治疗方法。

    Dienic derivatives of the androstane series and process
    4.
    发明授权
    Dienic derivatives of the androstane series and process 失效
    雄甾烷系列的二烯衍生物及其工艺

    公开(公告)号:US3919198A

    公开(公告)日:1975-11-11

    申请号:US43860274

    申请日:1974-02-01

    Applicant: ROUSSEL UCLAF

    Abstract: The present invention relates to a dienic derivative of the androstane series having the formula

    WHEREIN R is a member selected from the group consisting of hydrogen, alkyl having 1 to 4 carbon atoms and alkali metal, R'' and R'''' are members selected from the group consisting of 1) hydrogen and -COOM, respectively, where M is alkali metal, and 2) taken together, the divalent

    group, R2 is a member selected from the group consisting of hydrogen and methyl, with the proviso when R is hydrogen or alkyl having 1 to 4 carbon atoms, R'' and R'''' together are the divalent

    group; as well as their process of preparation.

    Abstract translation: 本发明涉及具有式WHEREIN R为选自氢,具有1至4个碳原子的烷基和碱金属的成员,R'和R“为选自以下的成员的雄甾烷系的二烯衍生物: 分别由1)氢和-COOM组成的组,其中M是碱金属,和2)合并在一起,二价-C-PARALLEL O基,R2是选自氢和甲基的成员,条件是 当R为氢或具有1至4个碳原子的烷基时,R'和R“一起为二价-C-PARALLEL O基; 以及他们的准备过程。

    Carbamaldoximes
    7.
    发明授权

    公开(公告)号:US3895039A

    公开(公告)日:1975-07-15

    申请号:US46447374

    申请日:1974-04-26

    Applicant: ROUSSEL UCLAF

    CPC classification number: C09D5/14

    Abstract: Novel carbamaldoximes of the formula

    WHEREIN Y is selected from the group consisting of hydrogen, chlorine and bromine and X is selected from the group consisting of phenyl optionally substituted with at least one member of the group consisting of halogen, cyano, -NO2, alkyl of 1 to 6 carbon atoms and alkoxy of 1 to 6 carbon atoms and nitrofuryl having fungicidal activity.

    Abstract translation: 式O的新型卡马尔肟共价XC = NOC-NH-C = CCl 2 I || YCl,其中Y选自氢,氯和溴,X选自任选被至少一个 由卤素,氰基,-NO 2,1至6个碳原子的烷基和1至6个碳原子的烷氧基组成的组的成员和具有杀真菌活性的硝基呋喃。

    Fungicidal carbamaldoximes
    8.
    发明授权
    Fungicidal carbamaldoximes 失效
    杀真菌性氨基甲肟酸

    公开(公告)号:US3887711A

    公开(公告)日:1975-06-03

    申请号:US48329074

    申请日:1974-06-26

    Applicant: ROUSSEL UCLAF

    CPC classification number: C09D5/14

    Abstract: Novel carbamaldoximes of the formula

    WHEREIN Y is selected from the group consisting of hydrogen, chlorine and bromine and X is selected from the group consisting of phenyl optionally substituted with at least one member of the group consisting of halogen, cyano, -NO2, alkyl of 1 to 6 carbon atoms and alkoxy of 1 to 6 carbon atoms and nitrofuryl having fungicidal activity.

    Abstract translation: 式VII的新型氨基甲肟酸选自氢,氯和溴,X选自任选被至少一个选自以下的一个基团取代的苯基:卤素,氰基,-NO 2, 1至6个碳原子的烷氧基和1至6个碳原子的烷氧基和具有杀真菌活性的硝基呋喃。

    Novel ' ' 9'- gonene-11-ones
    9.
    发明授权
    Novel ' ' 9'- gonene-11-ones 失效
    NOVEL''9'- GONENE-11-ONES

    公开(公告)号:US3876637A

    公开(公告)日:1975-04-08

    申请号:US43076974

    申请日:1974-01-04

    Applicant: ROUSSEL UCLAF

    Abstract: Wherein R is alkyl of 1 to 3 carbon atoms, R.sub.1 is selected from the group consisting of =0, ketals and
    R.sub.2 is selected from the group consisting of hydrogen and acyl of an organic carboxylic acid of 1 to 12 carbon atoms and X is selected from the group consisting of hydrogen and hydroxy which are valuable intermediates for the preparation of steroids such as adrenosterone.

    Racemates and optically active isomers of novel .DELTA..sup.9 gonene-11-ones of the formula

    Novel {66 {hu 9,11{b -Gonadiene-5{60 -ols
    10.
    发明授权
    Novel {66 {hu 9,11{b -Gonadiene-5{60 -ols 失效
    新型{66 {hu 9,11 {b-Gonadiene-5 {60-

    公开(公告)号:US3872092A

    公开(公告)日:1975-03-18

    申请号:US43356974

    申请日:1974-01-15

    Applicant: ROUSSEL UCLAF

    CPC classification number: C07J71/001 C07J7/0045 C07J21/006

    Abstract: Novel Delta 9,11-gonadiene-5 Alpha -ols of the formula

    WHEREIN R is alkyl of 1 to 4 carbon atoms, K is a blocked ketone in the form of a ketal, thioketal or methyloxime, preferably a ketal, and X is the rest of a pentagonal ring optionally substituted and their preparation which are useful intermediates for the preparation of Delta 4,9,11-gonatrienes.

    Abstract translation: 新型的具有1-4个碳原子的烷基的DELTA 9,11-雄二烯-5α-醇,K是酮缩酮,硫代缩酮或甲基肟,优选缩酮形式的封端酮,X是 剩余的五角环任选取代,它们的制备是制备DELTA 4,9,11-高三烯的有用的中间体。

Patent Agency Ranking